Mostrar el registro sencillo del ítem
dc.contributor.author | Lopez-Huertas, Maria Rosa | |
dc.contributor.author | Palladino, Claudia | |
dc.contributor.author | Garrido-Arquero, Marta | |
dc.contributor.author | Esteban-Cartelle, Beatriz | |
dc.contributor.author | Sanchez-Carrillo, Marta | |
dc.contributor.author | Martinez-Roman, Paula | |
dc.contributor.author | Martín-Carbonero, Luz | |
dc.contributor.author | Ryan, Pablo | |
dc.contributor.author | Domínguez-Domínguez, Lourdes | |
dc.contributor.author | De Los Santos, Ignacio | |
dc.contributor.author | De La Fuente Moral, Sara | |
dc.contributor.author | Benito, José Miguel | |
dc.contributor.author | Rallón, Norma | |
dc.contributor.author | Alcamí, José | |
dc.contributor.author | Resino, Salvador | |
dc.contributor.author | Fernandez-Rodriguez, Amanda | |
dc.contributor.author | Coiras, Mayte | |
dc.contributor.author | Briz, Veronica | |
dc.date.accessioned | 2020-01-15T12:48:58Z | |
dc.date.available | 2020-01-15T12:48:58Z | |
dc.date.issued | 2019-04-03 | |
dc.identifier.citation | Sci Rep. 2019 Apr 3;9(1):5606. | es_ES |
dc.identifier.issn | 2045-2322 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/8888 | |
dc.description.abstract | In HIV-1/HCV-coinfected patients, chronic HCV infection leads to an increased T-lymphocyte immune activation compared to HIV-monoinfected patients, thereby likely contributing to increase HIV-1 reservoir that is the major barrier for its eradication. Our objective was to evaluate the influence of HCV coinfection in HIV-1 viral reservoir size in resting (r) CD4+ T-cells (CD25-CD69-HLADR-). Multicenter cross-sectional study of 97 cART-treated HIV-1 patients, including 36 patients with HIV and HCV-chronic co-infection without anti-HCV treatment, 32 HIV patients with HCV spontaneous clearance and 29 HIV-monoinfected patients. rCD4+ T-cells were isolated and total DNA was extracted. HIV viral reservoir was measured by Alu-LTR qPCR. Differences between groups were calculated with a generalized linear model. Overall, 63.9% were men, median age of 41 years and Caucasian. Median CD4+ and CD8+ T-lymphocytes were 725 and 858 cells/mm3, respectively. CD4+ T nadir cells was 305 cells/mm3. Proviral HIV-1 DNA size was significantly increased in chronic HIV/HCV-coinfected compared to HIV-monoinfected patients (206.21 ± 47.38 vs. 87.34 ± 22.46, respectively; P = 0.009), as well as in spontaneously clarified HCV co-infected patients when compared to HIV-monoinfected individuals (136.20 ± 33.20; P = 0.009). HIV-1/HCV co-infected patients showed a larger HIV-1 reservoir size in comparison to HIV-monoinfected individuals. This increase could lead to a greater complexity in the elimination of HIV-1 reservoir in HIV-1/HCV-coinfected individuals, which should be considered in the current strategies for the elimination of HIV-1 reservoir. | es_ES |
dc.description.sponsorship | The authors thank all the patients for their participation. Financial support was provided by the Instituto de Salud Carlos III to VB (PI15CIII/00031), by the Spanish Ministry of Economy and Competitiveness to MC (SAF2016–78480-R) and The SPANISH AIDS Research Network RD16CIII/0002/0001, RD16CIII/0002/0002 and RD16/0025/0013 - ISCIII – FEDER. MRLP is supported by ISCIII - Subdirección General de Evaluacion and European Funding for Regional Development (FEDER) (PIE 13/00040 and RD12/0017/0017 RETIC de SIDA). C.P. is supported by the Portuguese Fundação para a Ciência e Tecnologia (FCT) (grant number SFRH/BPD/77448/2011 is part of the EDCTP2 programme supported by the European Union). V.B., A.F.R. and N.R. are supported by the Miguel Servet programme from Fondo de Investigación Sanitaria (ISCIII) (grant number CP13/00098, CP14/CIII/00010 and CP14/00198, respectively). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Nature Publishing Group | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 30944340 | es_ES |
dc.format.volume | 9 | es_ES |
dc.format.number | 1 | es_ES |
dc.format.page | 5606 | es_ES |
dc.identifier.doi | 10.1038/s41598-019-41788-9 | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | |
dc.contributor.funder | Red de Investigación Cooperativa en Investigación en Sida (España) | |
dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 2045-2322 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1038/s41598-019-41788-9 | es_ES |
dc.identifier.journal | Scientific reports | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI15CIII/00031 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2016–78480-R | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD16CIII/0002/0001 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD16CIII/0002/0002 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD16/0025/0013 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/PIE 13/00040 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD12/0017/0017 RETIC de SIDA | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/SFRH/BPD/77448/2011 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/CP13/00098 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/CP14/CIII/00010 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/CP14/00198 | es_ES |
dc.rights.accessRights | open access | es_ES |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Centro Nacional de Microbiología (CNM)
-
i+12 - Instituto de Investigación Hospital 12 de Octubre (Madrid)
-
IdiPAZ - Instituto de Investigación Sanitaria Hospital La Paz (Madrid)
-
IIS-FJD - Instituto de Investigación Sanitaria Fundación Jiménez Díaz (Madrid)
-
IRYCIS - Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)